8-Aminoisoquinoline CAS 23687-27-6

Introduction:Basic information about 8-Aminoisoquinoline CAS 23687-27-6, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.

8-Aminoisoquinoline Basic information

Product Name:8-Aminoisoquinoline
Synonyms:8-AMINOISOQUINOLINE;ISOQUINOLIN-8-AMINE;ISOQUINOLIN-8-YLAMINE;8-Aminoisoquinoline95%;8-Aminoisoquinoline 98%;8-amine-isoquinoline;8-Isoquinolinamine;8-Aminoisoquinoline ,98%
CAS:23687-27-6
MF:C9H8N2
MW:144.17
EINECS:691-616-4
Product Categories:Building Blocks;Isoquinoline;Amines;blocks;Quinolines;Quinoline&Isoquinoline;Heterocyclic Series
Mol File:23687-27-6.mol

8-Aminoisoquinoline Chemical Properties

Melting point 155-157
Boiling point 335.7±17.0 °C(Predicted)
density 1.210±0.06 g/cm3(Predicted)
storage temp. Keep in dark place,Inert atmosphere,2-8°C
form Crystalline Powder
pka6.20±0.23(Predicted)
color Brown
InChIInChI=1S/C9H8N2/c10-9-3-1-2-7-4-5-11-6-8(7)9/h1-6H,10H2
InChIKeyGUSYANXQYUJOBH-UHFFFAOYSA-N
SMILESC1C2=C(C=CC=C2N)C=CN=1
CAS DataBase Reference23687-27-6(CAS DataBase Reference)

Safety Information

Hazard Codes Xi
Risk Statements 41
Safety Statements 26-39
WGK Germany WGK 3
Hazard Note Harmful/Irritant/Keep Cold
HS Code 29334900
Storage Class11 - Combustible Solids
Hazard ClassificationsAcute Tox. 4 Oral
Eye Dam. 1

8-Aminoisoquinoline Usage And Synthesis

Chemical PropertiesBrown solid
Uses8-Aminoisoquinoline and its derivatives are used as intermediates for antimalarial drugs in the pharmaceutical field. For example, their structure is similar to the antimalarial drug primaquine.
Synthesis

63927-23-1

23687-27-6

General procedure for the synthesis of 8-aminoisoquinolines from 5-bromo-8-nitroisoquinolines: 5-bromo-8-nitroisoquinolines (1.00 g, 3.95 mmol) were dissolved in methanol (70 mL), and hydrogenation was carried out by adding palladium/activated charcoal (10% Pd, 200 mg) as a catalyst for 18 hr at room temperature and atmospheric pressure. Upon completion of the reaction, the reaction mixture was filtered through Celite to remove the catalyst. The filtrate was concentrated and purified by column chromatography (eluent: ethyl acetate/heptane) to afford the target compound 8-aminoisoquinoline (100 mg, 18% yield) as a greenish-brown solid.1H NMR (DMSO-d6, 400 MHz) δ 9.43 (s, 1H), 8.32 (d, 1H), 7.54 (d, 1H), 7.40 (dd, 1H) , 6.99 (d, 1H), 6.72 (d, 1H), 6.22 (s, 2H).

References[1] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 4, p. 803 - 806
[2] Journal of Medicinal Chemistry, 2005, vol. 48, # 3, p. 744 - 752
[3] Patent: WO2009/130481, 2009, A1. Location in patent: Page/Page column 143
[4] Journal of Medicinal Chemistry, 2005, vol. 48, # 15, p. 4972 - 4982
[5] Patent: WO2006/32851, 2006, A1. Location in patent: Page/Page column 49

8-Aminoisoquinoline Preparation Products And Raw materials

Raw materialsEthyl acetate-->Methanol-->Diethyl ether-->Sulfuric acid-->PETROLEUM ETHER-->Sodium carbonate-->Sodium sulfate-->Magnesium sulfate-->Triethylamine-->Ammonium hydroxide-->Sodium chloride-->Hexane-->Hydrogen-->N-Bromosuccinimide-->Ammonium acetate-->Potassium nitrate-->Palladium hydroxide-->Heptane-->Isoquinoline
8-Amino-1-naphthol-3,6-disulfonic acid monosodium salt monohydrate CAS 5460-09-3
8-Azaspiro[Bicyclo[3.2.1]Octane-3,4'-Imidazolidine]-2',5'-Dione CAS 77398-55-1
Recommended......
TOP